{"id":"NCT00075946","sponsor":"Eastern Cooperative Oncology Group","briefTitle":"Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma","officialTitle":"Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens For Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-01-23","primaryCompletion":"2013-09","completion":"2021-08","firstPosted":"2004-01-14","resultsPosted":"2015-06-22","lastUpdate":"2024-02-01"},"enrollment":545,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Lymphoma"],"interventions":[{"type":"BIOLOGICAL","name":"rituximab","otherNames":[]}],"arms":[{"label":"Arm A: Rituximab Retreatment","type":"ACTIVE_COMPARATOR"},{"label":"Arm B: Rituximab Scheduled","type":"EXPERIMENTAL"}],"summary":"RATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. It is not yet known which rituximab regimen is more effective in treating indolent non-Hodgkin's lymphoma.\n\nPURPOSE: This randomized phase III trial is studying two different schedules of rituximab and comparing them to see how well they work in treating patients with low tumor burden indolent stage III non-Hodgkin's lymphoma or stage IV non-Hodgkin's lymphoma.","primaryOutcome":{"measure":"Time to Rituximab Failure (TTRF)","timeFrame":"Assessed (by restaging CT scans) 26 weeks Â± 2 weeks from each rituximab treatment (including induction), counting the first rituximab dose as Day 1, until rituximab failure observed or July 17, 2013, whichever occurred first.","effectByArm":[{"arm":"Rituximab Retreatment: Follicular Patients","deltaMin":3.92,"sd":null},{"arm":"Rituximab Scheduled: Follicular Patients","deltaMin":4.32,"sd":null},{"arm":"Rituximab Retreatment: Non-Follicular Patients","deltaMin":1.39,"sd":null},{"arm":"Rituximab Scheduled: Non-Follicular Patients","deltaMin":4.83,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.33"},{"comp":"OG002 vs OG003","p":"0.012"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":11},"locations":{"siteCount":483,"countries":["United States"]},"refs":{"pmids":["25154829","35787017"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":23,"n":500},"commonTop":["Fatigue"]}}